J. Brinkmann Et Al. , "The clinical significance ofA2ML1variants in Noonan syndrome has to be reconsidered," EUROPEAN JOURNAL OF HUMAN GENETICS , vol.29, no.3, pp.524-527, 2021
Brinkmann, J. Et Al. 2021. The clinical significance ofA2ML1variants in Noonan syndrome has to be reconsidered. EUROPEAN JOURNAL OF HUMAN GENETICS , vol.29, no.3 , 524-527.
Brinkmann, J., Lissewski, C., Pinna, V., Vial, Y., Pantaleoni, F., Lepri, F., ... Daniele, P.(2021). The clinical significance ofA2ML1variants in Noonan syndrome has to be reconsidered. EUROPEAN JOURNAL OF HUMAN GENETICS , vol.29, no.3, 524-527.
Brinkmann, Julia Et Al. "The clinical significance ofA2ML1variants in Noonan syndrome has to be reconsidered," EUROPEAN JOURNAL OF HUMAN GENETICS , vol.29, no.3, 524-527, 2021
Brinkmann, Julia Et Al. "The clinical significance ofA2ML1variants in Noonan syndrome has to be reconsidered." EUROPEAN JOURNAL OF HUMAN GENETICS , vol.29, no.3, pp.524-527, 2021
Brinkmann, J. Et Al. (2021) . "The clinical significance ofA2ML1variants in Noonan syndrome has to be reconsidered." EUROPEAN JOURNAL OF HUMAN GENETICS , vol.29, no.3, pp.524-527.
@article{article, author={Julia Brinkmann Et Al. }, title={The clinical significance ofA2ML1variants in Noonan syndrome has to be reconsidered}, journal={EUROPEAN JOURNAL OF HUMAN GENETICS}, year=2021, pages={524-527} }